ID   7E3
AC   CVCL_J935
DR   CLO; CLO_0001498
DR   ATCC; HB-8832
DR   Wikidata; Q54605106
RX   Patent=US5976532;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8832.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the chimeric abciximab (ReoPro) therapeutic antibody which is used as a platelet aggregation inhibitor.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 11
//
RX   Patent=US5976532;
RA   Coller B.S., Knight D.M.;
RT   "Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies
RT   or fragments thereof, including c7E3.";
RL   Patent number US5976532, 02-Nov-1999.
//